Hence, while ZEB1 and ZEB2 are largely co-expressed in mesenchymal tumor cells and display similar oncogenic roles in epithelial cell-derived carcinomas, they display opposite expression patterns and functions in melanocytes and melanoma cells, which partly rely on the antagonistic regulation of the master gene MITF. This evidence concerns the gene ZEB2 and carcinoma.